Omega Healthcare director granted 6,125 shares

Omega Healthcare Investors director Kevin J. Jacobs received an equity grant of 6,125 shares of Common Stock as director compensation.

Rhea-AI Filing Summary

Omega Healthcare Investors director Kevin J. Jacobs received an equity grant of 6,125 shares of Common Stock as director compensation. The award was granted on June 5, 2026 under a Restricted Stock Grant Award Agreement at a reference price of $43.67 per share.

According to the terms, the restricted shares will vest on the date of the company’s 2027 Annual Meeting of Shareholders, approximately one year from the grant date, and will convert to common stock on a one-for-one basis. After this grant, Jacobs directly holds 46,935 shares of Omega Healthcare Investors common stock.

Insider Trade Summary

Grant/Award: 6,125 shares

Grant/Award 1 txn

Insider Jacobs Kevin J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	6,125	$43.67	$267K

Holdings After Transaction: Common Stock — 46,935 shares (Direct)

Footnotes (1)

1. F1. Represents Director compensation granted on June 5, 2026 via a Restricted Stock Grant Award Agreement which will vest on the date of the Company's 2027 Annual Meeting of Shareholders, which is approximately one (1) year from the date of the grant and will convert to common stock on a one-for-one basis.

Key Figures

Restricted stock granted: 6,125 shares Grant price per share: $43.67 per share Shares held after grant: 46,935 shares +2 more

5 metrics

Restricted stock granted 6,125 shares Director compensation grant on June 5, 2026

Grant price per share $43.67 per share Reported price for restricted stock award

Shares held after grant 46,935 shares Total direct holdings following June 5, 2026 grant

Vesting timing 2027 Annual Meeting Restricted stock vests at 2027 Annual Meeting of Shareholders

Conversion ratio 1-for-1 Restricted stock converts to common stock one-for-one at vesting

Key Terms

Restricted Stock Grant Award Agreement, vest, Annual Meeting of Shareholders, convert to common stock on a one-for-one basis

4 terms

Restricted Stock Grant Award Agreement financial

"granted on June 5, 2026 via a Restricted Stock Grant Award Agreement which will vest"

vest financial

"which will vest on the date of the Company's 2027 Annual Meeting of Shareholders"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Annual Meeting of Shareholders financial

"vest on the date of the Company's 2027 Annual Meeting of Shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

convert to common stock on a one-for-one basis financial

"and will convert to common stock on a one-for-one basis"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Omega Healthcare (OHI) disclose about Kevin J. Jacobs in this Form 4?

Omega Healthcare reported that director Kevin J. Jacobs received 6,125 shares of Common Stock as director compensation. The award was granted on June 5, 2026 and is structured as restricted stock subject to a vesting schedule tied to the 2027 Annual Meeting.

How many Omega Healthcare (OHI) shares did Kevin J. Jacobs receive and at what price reference?

Kevin J. Jacobs received 6,125 shares of Omega Healthcare Common Stock as a grant, with a reported price per share of $43.67. This reflects the grant’s reference value for reporting purposes, not an open-market purchase or sale by the director.

When do Kevin J. Jacobs’s restricted Omega Healthcare (OHI) shares vest?

The restricted stock granted to Kevin J. Jacobs will vest on the date of Omega Healthcare’s 2027 Annual Meeting of Shareholders. The footnote states this vesting date is approximately one year from the June 5, 2026 grant date, aligning the award with the next annual meeting.

What happens to the restricted shares from Kevin J. Jacobs’s Omega Healthcare (OHI) grant at vesting?

At vesting, the restricted stock granted to Kevin J. Jacobs will convert to common stock on a one-for-one basis. This means each restricted share becomes one share of common stock, consistent with the terms described in the Restricted Stock Grant Award Agreement.

How many Omega Healthcare (OHI) shares does Kevin J. Jacobs hold after this Form 4 transaction?

Following this grant, Kevin J. Jacobs directly holds 46,935 shares of Omega Healthcare Common Stock. This post-transaction figure includes the newly granted restricted shares and represents his total reported direct ownership after the June 5, 2026 award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/09/2026 - 04:15 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jacobs Kevin J

(Last) (First) (Middle)

303 INTERNATIONAL CIRCLE

SUITE 200

(Street)

HUNT VALLEY MARYLAND 21030

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
OMEGA HEALTHCARE INVESTORS INC [ OHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/05/2026		A		6,125(1)	A	$43.67	46,935	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents Director compensation granted on June 5, 2026 via a Restricted Stock Grant Award Agreement which will vest on the date of the Company's 2027 Annual Meeting of Shareholders, which is approximately one (1) year from the date of the grant and will convert to common stock on a one-for-one basis.

	/s/ Meghan C. Lyons, Attorney-in-Fact	06/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)